At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 56 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
- September 29, 2023
First Cancer Moonshot Award Announced at Yale School of Medicine
- September 29, 2023
“Complete Academic Physician” Dr. Karl Insogna Retires From Clinical Duties
- September 29, 2023
New Yale Cancer Center Research Highlighted at Top Radiation Oncology Conference
- September 28, 2023Source: OncLive
Dr. Amer Zeidan Highlights Key Implications of the COMMANDS Trial in Lower-Risk MDS
- September 28, 2023
Meet Yale Internal Medicine: Jacquelyne Gaddy, MD, MSc, MSCR, Assistant Professor of Medicine (Medical Oncology)
- September 28, 2023Source: The ASCO Post
Does Colon Tumor Location Play a Role in Metastasis and Survival?
- September 28, 2023Source: Targeted Oncology
Dr. Petrylak Reviews Results From KEYNOTE-921 in mCRPC
- September 27, 2023
$20M Federal Grant Renewed for Yale Tobacco Center of Regulatory Science
- September 27, 2023Source: Targeted Oncology
Radioligand Therapy Improves PFS and Responses in SSTR+ Grade 2/3 GEP-NETs
- September 27, 2023
Celebration for Christina Holt, MSN, APRN (BC), ACHPN, OCN
- September 26, 2023
Exploring Transgender People’s Experiences With Health Care
- September 26, 2023Source: HealthDay
Stigma, Even Harm Common When Transgender People Meet With Doctors